The abstract is read at the publisher; the summary is JClub's.
Engineered monocytes and macrophages are emerging therapeutic platforms, and coordinating sensing, signal integration, actuation, and delivery is linked to tissue exposure, durability, and pharmacodynamic readouts.
- Why it matters: Early clinical feasibility exists, but recognizing targets alone does not ensure sustained function after cells enter tissues, limiting durable therapeutic effects.
- What they did: The work reviews recent advances across myeloid-adapted receptors, context-responsive circuits, checkpoint and metabolic engineering, in vivo mRNA delivery, and stem-cell-derived platforms, organizing them into four coupled layers.
- The result: Framing these therapies as integrated pharmacological systems helps clarify how layer coordination can improve tissue tracking, control plasticity, and sustain effector capacity across therapeutic settings.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.